Broadcom
AVGO
Micron Technology
MU
Adobe
ADBE
Alibaba
BABA
Oracle
ORCL
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 4.030
- +0.030+0.75%
Trading Dec 26 13:40 ET
276.25MMarket Cap-1.05P/E (TTM)
4.150High3.921Low438.39KVolume3.940Open4.000Pre Close1.78MTurnover1.03%Turnover Ratio5.76P/E (Static)68.55MShares19.94952wk High1.41P/B170.84MFloat Cap1.57552wk Low--Dividend TTM42.39MShs Float41.930Historical High--Div YieldTTM5.74%Amplitude1.575Historical Low4.060Avg Price1Lot Size
Amylyx Pharmaceuticals Key Stats
EPS
According to the latest financial report of Amylyx Pharmaceuticals, the latest earnings per share (TTM) for the company is -1.07. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Amylyx Pharmaceuticals's free cash flow? The latest report shows it as -41.55M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Amylyx Pharmaceuticals shows that the company's current ratio is 4.55, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Amylyx Pharmaceuticals, the quick ratio is 4.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Amylyx Pharmaceuticals? The latest ROE figure is -31.78%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Amylyx Pharmaceuticals, the total asset return on investment (ROA) is -24.95%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Amylyx Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at -94.47%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Amylyx Pharmaceuticals, the net profit margin is -17.48K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.